Parallel electromembrane extraction in a multiwell plate.
This paper describes the concept of parallel electromembrane extraction (Pa-EME) with flat membranes in a multiwell format for the first time. The setup is based on a multiwell plate and provided simultaneous and selective isolation, cleanup, and enrichment of several human plasma samples as well as LC-MS-compatible extracts within 8 min of extraction. Undiluted human plasma samples spiked with four antidepressant drugs were added to separate wells in the donor plate. Subsequently, the samples were extracted with Pa-EME. The four drugs migrated electrokinetically from undiluted human plasma through a flat polypropylene membrane impregnated with 2-nitrophenyl octyl ether, and were isolated into formic acid. Extraction time, extraction voltage, agitation rate, sample volume, and acceptor solution volume were all optimized with an experimental design. The optimal conditions were as follows: The agitation rate was 1,040 rpm, and an extraction voltage of 200 V was applied. The sample volume and acceptor solution volume was 240 and 70 μL, respectively. The extraction was continued for 8 min. Eventually, the extracts were analyzed by LC-MS/MS. The combination of Pa-EME with LC-MS/MS provided quantitation limits below the therapeutic level and reported relative standard deviations in the range 5-13 %. Linear calibration curves were obtained for all analytes, and the correlation coefficients were above 0.9974 in the range 1-400 ng mL(-1). The drug concentrations from two subjects treated with quetiapine and sertraline were successfully determined with Pa-EME combined with LC-MS/MS. Post-column infusion experiments demonstrated that Pa-EME provided extracts free from interfering matrix components.
School of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316, Oslo, Norway.
Lars Erik Eng
LE
Eibak
Marthe Petrine
MP
Parmer
Knut Einar
KE
Rasmussen
Stig
S
Pedersen-Bjergaard
Astrid
A
Gjelstad
D000639:Amitriptyline; D014150:Antipsychotic Agents / Q000097:blood; D002138:Calibration; D002853:Chromatography, Liquid; D003987:Dibenzothiazepines / Q000097:blood; D055664:Electrochemical Techniques / Q000379:methods*; D004987:Ethers / Q000737:chemistry*; D005473:Fluoxetine; D006801:Humans; D057230:Limit of Detection; D008567:Membranes, Artificial; D000069348:Quetiapine Fumarate; D020280:Sertraline / Q000097:blood; D052616:Solid Phase Extraction / Q000379:methods*; D053719:Tandem Mass Spectrometry; D013997:Time Factors
C519952:2-nitrophenyl octyl ether; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D004987:Ethers; D008567:Membranes, Artificial; D005473:Fluoxetine; D000639:Amitriptyline; D000069348:Quetiapine Fumarate; D020280:Sertraline